Skip to content

DR. BIJNENS ERIC

Active Private limited companyfounded 2006active for 20 yearsLaagsimsestraat 31, 3570 AlkenKBO/BCE: BE 0879.863.343 #8 company by total assets in Alken, Health and social work sector

Lifetime

20 annual accounts with figures on one time axis
peak of €476,587 in 2025
€476,587▲ 13.5%
peak of €314,100 in 2025
€314,100▲ 14.3%
peak of €1.5m in 2024
€1.1m▼ 26.0%
€465,343▼ 12.4%
Board1 name since 2021
1 director
Documentsfilings and deeds
12-05-202680 days before the deadline
2025micro format
Gross margin from €419,874 to €476,587Dividend €716,072Equity from €1.5m to €1.1m

Key points

from the 2025 annual accounts

Equity

€1.1m ▼ 26.0%
1.52024+0.3Profit-0.7Dividend1.12025

DR. BIJNENS ERIC paid out €716,072 in dividends. That is 228% of the 2025 profit.

Filings

20 annual accounts since 2006
AprilJune31 JulyOctober2010201520202025

The last five annual accounts were filed 3 to 80 days before the end of the period.

Position in the sector

€314,100

Higher net result than 95% of companies in human health. The sector median is €59,520, over 21,384 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,155 companies had the same profile as DR. BIJNENS ERIC has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,155 companies, not a prediction for DR. BIJNENS ERIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • deed of 12-12-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0879863343
changes role from statutory director to director Discharge granted to · General meeting of 09-03-2022 · Gazette deed
Capital decrease of €375,028.53 to €18,600 The capital fell from €393,628.53 to €18,600 · Gazette deed
Capital increase of €375,028.53 to €393,628.53 After the increase, the capital stands at €393,628.53 · Contribution by · General meeting of 09-12-2013 · Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company
DR. BIJNENS ERIC Alken €1.6m €476,587 71.1% -
Dr. Bleus - Dr. Cambier Hasselt €1.5m €491,973 50.8% -
DOKTER DAMS Heusden-Zolder €1.7m €448,992 75.6% -
DR.LF.LIESENBORGHS Sint-Truiden €1.4m €448,237 82.9% 0.9
Dr. Kris Van De Moortele Jabbeke €1.6m €482,353 66.0% -
Dr. Langlois Aalter €1.6m €476,052 97.1% -
GUBIN DE GRAVE Mouscron €1.6m €500,049 48.0% -

These companies have the same main activity as DR. BIJNENS ERIC: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.4m and €1.7m, founded between 2004 and 2008.

Official details

Source: KBO
Status
Active since 24-02-2006Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
31 December
Peppol
Reachable since 17-12-2025
Company details

Annual accounts 2025

≈ €720,000estimated
€1.6m▼ 22.5%
Filing
Filed on 12-05-2026, 80 days before the end of the filing period
Financials

Insights on DR. BIJNENS ERIC

DR. BIJNENS ERIC files the micro format. That format states no turnover. The gross margin rose from €370,421 in 2006 to €476,587 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. BIJNENS ERIC

What is the company number of DR. BIJNENS ERIC?
The company number of DR. BIJNENS ERIC is 0879.863.343. The VAT number is the same number with BE in front: BE 0879.863.343.
Where is DR. BIJNENS ERIC based?
The registered office is at Laagsimsestraat 31, 3570 Alken.Company details
What does DR. BIJNENS ERIC do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. BIJNENS ERIC?
DR. BIJNENS ERIC is a private limited company (BV).
When was DR. BIJNENS ERIC founded?
DR. BIJNENS ERIC was founded on 24-02-2006.
Is DR. BIJNENS ERIC still active?
Yes, DR. BIJNENS ERIC is an active enterprise in the KBO register.
What is the turnover of DR. BIJNENS ERIC?
The turnover in financial year 2025 is about €720,000. This figure is estimated from the gross margin of €476,587 and 31 comparable companies (NACE 86220). It probably lies between €640,000 and €1.0m.Financials
Is DR. BIJNENS ERIC profitable?
In financial year 2025, DR. BIJNENS ERIC made a profit of €314,100.
Where can I find the annual accounts of DR. BIJNENS ERIC?
DR. BIJNENS ERIC filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. BIJNENS ERIC due?
DR. BIJNENS ERIC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.